Is Ketamine Therapy Legal? What You Need to Know

,
Ketamine therapy is legal in the United States when it's prescribed by a licensed professional and administered in a clinical setting. Learn more about this...

Ketamine therapy is legal in the United States when it’s prescribed by a licensed professional and administered in a clinical setting. Learn more about this innovative treatment and safe administration at BNI Clinics.

Key Takeaways

  • Ketamine therapy is legal in the United States when medically prescribed. It’s a Schedule III controlled substance, meaning it has legitimate medical use, alongside a risk of psychological dependence. Therefore, it must be used under clinical guidance.
  • The treatment is typically used for treatment-resistant depression, providing faster results than traditional antidepressants. However, it may also reduce symptoms of anxiety, PTSD, and chronic pain conditions.
  • Ensure ketamine is administered safely and legally by working with a clinic that provides medical screening, monitoring, therapy alongside treatment, and can show their credentials and sourcing.

Table of Contents

Introduction

Ketamine has a split identity in America. On the one hand, it’s an anesthetic and FDA-approved therapy for treatment-resistant depression. On the other hand, it’s “Special K”, a street drug associated with club culture and celebrity deaths.

Is ketamine therapy legal-yes, when administered in a clinical setting with medical oversight

So is ketamine therapy legal? It is when a licensed medical professional prescribes and administers it, with federal scheduling, prescribing rules, and clinical oversight. This article provides information about the legal picture so people struggling with mental health conditions can ensure safe treatment.

Ketamine is categorized as a Schedule III controlled substance under the Federal Controlled Substances Act. The status was finalized in 1999, after the DEA found it had a legitimate medical use but also had potential for abuse and psychological dependence. It’s placed in the same risk tier as anabolic steroids and certain barbiturates, meaning it’s controlled and tightly regulated, as compared to Schedule I substances, which are highly addictive with no medical benefits.

As a Schedule III drug, ketamine can only be manufactured, distributed, and dispensed by DEA-registered practitioners and pharmacies. Prescriptions are subject to standard controlled-substance rules, including refill limits and record-keeping requirements.

The History of Ketamine’s Legality

Ketamine was FDA-approved as an anesthetic in the 1970s, and that stands today. Its use as a mental health treatment came much later.

In 2019, the nasal spray Spravato received FDA approval for treatment-resistant depression when used alongside an oral antidepressant. In January 2025, the approval expanded, clearing Spravato as the first and only standalone (monotherapy) treatment for adults with treatment-resistant major depressive disorder who hadn’t responded to at least two other antidepressants.

Because of the risk of sedation, dissociation, and misuse, Spravato is only available through a restricted federal distribution program and must be administered in a certified medical setting, with the patient monitored for at least two hours afterward.

Off-Label Ketamine & State Regulations

Other administration methods include intramuscular and intravenous ketamine therapy. While not FDA-approved, they can be legally prescribed off-label, which can make insurance coverage difficult. However, these off-label prescriptions are largely responsible for ketamine’s growth and accessibility.

State-level regulation also applies. Most states don’t have ketamine-specific therapy statutes, so clinics typically operate under each state’s general medical practice and controlled-substance laws, meaning oversight can vary based on who’s allowed to prescribe, supervise, and administer the drug locally.

Prescribed vs. Recreational Use: What Are the Key Differences?

Whether ketamine use can be considered prescribed or recreational depends on the setting, supervision, source, quality, purpose, dosing, and legal exposure.

  • Setting & Supervision: Legal administration occurs in ketamine clinics with careful oversight and vital sign monitoring. None of that applies in recreational use.
  • Source & Quality: Clinics use pharmaceutical-grade ketamine from regulated suppliers, with known concentration and purity. Ketamine obtained illegally is frequently cut with other substances, often with no set dosage.
  • Purpose & Dosing: In a clinical setting, medical professionals prescribe ketamine based on the client’s biological factors and medical needs. Recreationally, there are no dosing regulations, and the purpose is to get high rather than target mental health disorders.
  • Legal Exposure: Possessing or using ketamine without a valid prescription is a federal offense, and penalties vary by state. Even though the drug is federally decriminalized in a medical context, the DEA’s scheduling structure means unauthorized possession or distribution still carries criminal consequences. And the illegal side of the market is growing fast: according to a JAMA Psychiatry study, illicit ketamine seizures by U.S. drug enforcement jumped 349% between 2017 and 2022 — from 55 seizures to 247 — with the total weight seized climbing more than 1,100% over the same period.

How Does Ketamine Therapy Work?

Man receives ketamine therapy

Ketamine therapy can be administered via Spravato nasal spray, intramuscular injection, or intravenously. Unlike traditional antidepressants that make serotonin and/or norepinephrine more readily available, it blocks NMDA receptors to produce a glutamate surge, activating receptors that promote synaptic growth and plasticity, relieving depression in hours or days rather than weeks.

One pooled analysis published in the Journal of Clinical Psychiatry of 97 treatment-resistant depression patients found a 67% response rate (defined as at least a 50% reduction in depression symptoms).

While mainly prescribed for treatment-resistant depression, some research suggests ketamine may relieve symptoms associated with other psychiatric disorders, such as anxiety and post-traumatic stress disorder, as well as some chronic pain conditions.

Initial treatment typically involves six infusions over two to three weeks. Follow-up sessions are typically required for ongoing maintenance.

What Should I Expect From a Licensed Clinic?

A licensed clinic should offer verifiable credentials and administer ketamine treatment after a medical screening and with on-site monitoring. A therapy component is typically included.

  • Verifiable Credentials: Ketamine clinics should be staffed with licensed physicians and a medical director. They should be transparent about sourcing and dosage.
  • Medical Screening: Patients should be thoroughly screened before ketamine therapy begins to ensure a safe process.
  • On-site Monitoring: The patient’s vital signs should be monitored throughout the process to reduce the risk of complications.
  • Therapy Component: Ketamine is typically paired with therapy, as psychological work makes it more effective in treating mental health issues.

If a clinic skips the medical screening, doesn’t have medical staff on site during administration, is vague about their sourcing or credentials, or treats ketamine like more of a wellness trend than a medical procedure, you may want to think twice about using their services.

BNI Clinics Is a Top Provider of Safe Ketamine Therapy

BNI is one of the top ketamine clinics Los Angeles, with almost 20 years of experience. We offer an experienced team of medical and mental health practitioners, personalized plans combined with psychotherapy and medication support, and fully supervised treatments. Our team will guide you through the process, providing the assistance you need to manage severe depression.

Contact us to learn more about our treatment protocols.

FAQs

Is ketamine legal in the US?

Yes, ketamine is legal in the U.S. As a Schedule III controlled substance, it is legal when prescribed and administered by a licensed medical provider. Recreational or unsupervised use is illegal nationwide.

Do I need a prescription for ketamine therapy?

Yes. A licensed physician must prescribe ketamine, either off-label (standard IV/IM ketamine) or as FDA-approved Spravato (esketamine) for treatment-resistant depression.

What conditions is ketamine therapy used for?

Ketamine therapy is most commonly prescribed for treating depression. However, it may also help with PTSD, anxiety, and chronic pain conditions.

Is ketamine addictive?

Yes, ketamine can be addictive. It carries a real risk of psychological dependence, which is part of why the DEA classifies it as Schedule III. In a supervised clinical setting with controlled dosing, that risk is managed; unsupervised or self-directed use raises it considerably.

Is ketamine legal in every state?

There’s no state-by-state ban on ketamine therapy, but most states don’t have ketamine-specific statutes either. Clinics operate under general state medical-practice and controlled-substance laws, so oversight and provider requirements can vary by state.

Sources

  1. Schedules of Controlled Substances: Placement of Ketamine into Schedule III. Federal Register / U.S. Drug Enforcement Administration. https://www.govinfo.gov/content/pkg/FR-1999-07-13/html/99-17803.htm
  2. FDA Approves New Nasal Spray Medication for Treatment-Resistant Depression. U.S. Food and Drug Administration (via BioSpace release archive). https://www.biospace.com/fda-approves-new-nasal-spray-medication-for-treatment-resistant-depression-available-only-at-a-certified-doctor-s-office-or-clinic
  3. FDA Approves Spravato as Monotherapy for Adults With Major Depressive Disorder. Healio. https://www.healio.com/news/psychiatry/20250122/fda-approves-spravato-as-monotherapy-for-adults-with-major-depressive-disorder
  4. Major Depression statistics. National Institute of Mental Health. https://nimh.nih.gov/health/statistics/major-depression/
  5. Definition of Treatment-Resistant Depression in the Medicare Population. Agency for Healthcare Research and Quality / National Library of Medicine. https://ncbi.nlm.nih.gov/books/n/taid105/chapter2
  6. Oregon Governor Signs a Bill Recriminalizing Drug Possession. Associated Press via PBS NewsHour. https://www.pbs.org/newshour/politics/oregon-governor-signs-a-bill-recriminalizing-drug-possession
  7. Palamar JJ, Rutherford C, Keyes KM. Trends in Seizures of Illicit Ketamine, 2017-2022. JAMA Psychiatry (via NYU Grossman School of Medicine). https://nyulangone.org/news/node/30292
  8. Wan LB, et al. Ketamine Safety and Tolerability in Clinical Trials for Treatment-Resistant Depression. Journal of Clinical Psychiatry / National Library of Medicine (PubMed). https://pubmed.ncbi.nlm.nih.gov/25271445/
  9. Palamar JJ, Rutherford C, Keyes KM. Diversion of Undistributed Pharmaceutical Ketamine in the US. JAMA. https://jamanetwork.com/journals/jama/article-abstract/2827599
  10. Matthew Perry Death Ruled Accident From “Acute Effects of Ketamine.” Associated Press via PBS Los Angeles Bureau (via CBC News republish). https://www.cbc.ca/lite/story/1.7061255
  11. Doctor Who Supplied Ketamine to Matthew Perry Will Plead Guilty. Associated Press via PBS NewsHour. https://www.pbs.org/newshour/arts/doctor-who-supplied-ketamine-to-matthew-perry-will-plead-guilty
  12. Ketamine Queen Jasveen Sangha Sentenced to 15 Years in Connection With Matthew Perry’s Overdose Death. ABC News (via ABC30 republish). https://abc30.com/post/ketamine-queen-set-sentenced-matthew-perrys-overdose-death/18855938/